Literature DB >> 22811839

Hepatic necrosis and hemorrhage following hyperthermic intraperitoneal chemotherapy with oxaliplatin: A review of two cases.

Mila Bouchereau1, Mai-Kim Gervais, Lucas Sideris, Marie-Hélène Loriot, Stéphane P Ahern, Pierre Dubé.   

Abstract

Entities:  

Keywords:  complication oxaliplatin hyperthermic intraperitoneal chemotherapy; hepatic hemorrhage; intraperitoneal chemotherapy hepatic necrosis

Year:  2011        PMID： 22811839      PMCID： PMC3397607          DOI： 10.3978/j.issn.2078-6891.2011.012

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  14 in total

Review 1.  Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality.

Authors:  Terence C Chua; Tristan D Yan; Akshat Saxena; David L Morris
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

2.  Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis.

Authors:  Eric Marcotte; Lucas Sideris; Pierre Drolet; Andrew Mitchell; Suzanne Frenette; Guy Leblanc; Yves E Leclerc; Pierre Dubé
Journal:  Ann Surg Oncol       Date:  2008-07-25       Impact factor: 5.344

3.  Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis.

Authors:  D Elias; A El Otmany; M Bonnay; A Paci; M Ducreux; S Antoun; P Lasser; S Laurent; P Bourget
Journal:  Oncology       Date:  2002       Impact factor: 2.935

Review 4.  Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy.

Authors:  Paul H Sugarbaker; Jorge Torres Mora; Pablo Carmignani; O Anthony Stuart; Dal Yoo
Journal:  Oncologist       Date:  2005-02

5.  Peritoneal carcinomatosis of colorectal origin.

Authors:  Dominique Elias; Bruno Raynard; Ferechte Farkhondeh; Diane Goéré; Delphine Rouquie; Raoul Ciuchendea; Marc Pocard; Michel Ducreux
Journal:  Gastroenterol Clin Biol       Date:  2006-10

6.  Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy.

Authors:  Dominique Elias; Valérie Bedard; Tarek Bouzid; Pierre Duvillard; Niaz Kohneh-Sharhi; Bruno Raynard; Diane Goere
Journal:  Gastroenterol Clin Biol       Date:  2007-10

7.  Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.

Authors:  Wim P Ceelen; Marc Peeters; Philippe Houtmeyers; Christophe Breusegem; Filip De Somer; Piet Pattyn
Journal:  Ann Surg Oncol       Date:  2007-10-25       Impact factor: 5.344

8.  A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.

Authors:  John H Stewart; Perry Shen; Greg Russell; Joyce Fenstermaker; Libby McWilliams; Faith M Coldrun; Keith E Levine; Bradley T Jones; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2008-05-21       Impact factor: 5.344

9.  Fatal thrombocytopenia after oxaliplatin-based chemotherapy.

Authors:  Yu-Yun Shao; Ruey-Long Hong
Journal:  Anticancer Res       Date:  2008 Sep-Oct       Impact factor: 2.480

10.  Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?

Authors:  Tristan D Yan; David L Morris
Journal:  Ann Surg       Date:  2008-11       Impact factor: 12.969
View more
  5 in total

1.  Human amniotic fluid-derived stem cells can differentiate into hepatocyte-like cells in vitro and in vivo.

Authors:  Hui Liu; Da-qing Liu; Bao-wei Li; Li-dong Guan; Zhi-feng Yan; Ya-li Li; Xue-tao Pei; Wen Yue; Min Wang; Yan-ping Lu; Hong-mei Peng; Yang Lv
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-09-22       Impact factor: 2.416

Review 2.  Pseudomyxoma Peritonei: Case Report and Literature Review.

Authors:  Keishla M García; Karla M Flores; Alejandro Ruiz; Frances L González; Ángel M Rodríguez
Journal:  J Gastrointest Cancer       Date:  2019-12

3.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination.

Authors:  Xiao-Jiang Wu; Peng Yuan; Zi-Yu Li; Zhao-De Bu; Lian-Hai Zhang; Ai-Wen Wu; Xiang-Long Zong; Shuang-Xi Li; Fei Shan; Xin Ji; Hui Ren; Jia-Fu Ji
Journal:  Tumour Biol       Date:  2012-10-30

4.  Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis.

Authors:  Bharat Panuganti; Ea-Sle Chang; Cyril W Helm; Theresa Schwartz; Eddy C Hsueh; Jinhua Piao; Jinping Lai; Jula Veerapong
Journal:  Gastroenterology Res       Date:  2018-05-31

5.  Acute Liver Failure Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report.

Authors:  Pavneet Kohli; Prasanth Penumadu; Rajkumar Subramaniam
Journal:  Cureus       Date:  2019-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.